乳腺癌个体化治疗-多种分子诊断方案比较

乳腺癌个体化治疗-多种分子诊断方案比较

ID:16537180

大小:1.91 MB

页数:49页

时间:2018-08-22

乳腺癌个体化治疗-多种分子诊断方案比较_第1页
乳腺癌个体化治疗-多种分子诊断方案比较_第2页
乳腺癌个体化治疗-多种分子诊断方案比较_第3页
乳腺癌个体化治疗-多种分子诊断方案比较_第4页
乳腺癌个体化治疗-多种分子诊断方案比较_第5页
资源描述:

《乳腺癌个体化治疗-多种分子诊断方案比较》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、InPursuitofPersonalizedTherapyforBreastCancer:GeneExpressionSignaturesJaneS.Chawla,M.D.November6,2009ObjectivesCase:ChemotherapyorNOTWhoshouldreceiveadjuvantchemotherapy?Thebirthofgene-expressionsignatures:IntrinsicbreastcancersubtypesGeneExpressionSignaturesunderdevelopment70-geneS

2、ignature21-geneSignature2-geneSignature50-genesignatureCaserevisitedShouldthepatientreceivechemotherapy?ClinicalCase30y/oWFwithnewlydiagnosedIDCRbreastMMG/Ultrasound1.2x1.2cmmassat10o’clock+surroundingmicrocalcifications+severalsuspiciousaxillaryLNss/pbilateralmastectomiesatOSHSurg

3、icalPath-4.6cmlesionconsistingofIDCmixedwithDCIS;intermediategrade;+lymphovascularinvasion;11(-)LNs;ER+/PR+/HER-2-;T2N0M0OncotypeDX-->lowriskforrecurrenceBasedononcotyperesultsheroncologistrecommendedadjuvanttamoxifenx5yearsPtpresentsforasecondopinionHowelsecanwedifferentiatethesetu

4、mors?WhoShouldReceiveAdjuvantChemotherapy?65%ofwomenwithinvasivebreastcancerhaveLN(-)diseaseAdjuvantchemotherapyimprovesDFSandOSinpre-andpostmenopausalwomen<70withLN+/-breastcancerNSABPB-14&B-20showedthebenefitoftamoxifen&chemoinER+/LN-breastcancerLikelihoodofdistantmetsat10yearsisa

5、bout15%85%ofptsareovertreatedifchemogiventoallpatientsThosewithpoorprognosticfeaturesbenefitmostfromchemotherapyMainclinicalprognosticfactors:age,tumorsize,axillaryLNstatus,tumorhistology,grade,andhormone-receptorstatusSotiriou,C.etal.NEJM,2009.LuminalALuminalBHER2+Basal-likeIntrins

6、icBreastCancerSubtypesdescribedbyPerouetal.Express↑amountsOfluminalcyto-Keratins&geneticMarkersofluminalEpithelialcellsofNormaltissueExpress↑levelsofEGFR,c-kit,&growthfactorslikehepatocytegrowthfactorandIGFGeneExpressionProfilesor“Signatures”Composedofaselectionofgenesfelttoprovidep

7、rognosticorpredictiveinformationabouttumorsAnumberofgeneexpressionsignatureshavebeendevelopedtohelpidentifythosepatientsathighestriskforrecurrentdiseaseThismayavoidchemotherapyadministrationtopatientsatlowriskThe70-geneAssay:MammaPrintMammaprint:Developmentofthe70-GeneSignatureDNAmi

8、croarrayanalysisof7

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。